Back to 
MORGAN STANLEY
MORGAN STANLEY
BCTX4 quarters
Position history for MORGAN STANLEY's holdings in BRIACELL THERAPEUTICS CORP
Yes. Morgan Stanley holds 1,033 shares of BCTX (Briacell Therapeutics), worth $3,347, as of its Q2 2026 13F filing. It reduced the position by 1,988 shares (-65.8%) from Q1 2026. Morgan Stanley has held BCTX since Q3 2025, across 4 quarterly 13F filings.
Current Value
$3,347
Current Shares
1,033
Total Value Change
+$2,093
Total Shares Change
+919
Quarter-by-Quarter History
Other major holders of BCTX: UBS Group AG, CITADEL ADVISORS LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC